8 completed, 4 unknown, 3 recruiting. 3 Not applicable, 2 Phase 4, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Unknown 2, Recruiting 1 |
| Phase 4 | 2 | Recruiting 1, Unknown 1 |
| Phase 2 | 1 | Completed 1 |
Follow Nonvalvular Atrial Fibrillation: new trials by email Literature Review of Nonvalvular Atrial Fibrillation trials Research Report on Nonvalvular Atrial Fibrillation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| TEE-Guided Versus CCTA-Guided Preprocedural Imaging for Left Atrial Appendage Closure Transesophageal Echocardiography-Guided Preprocedural Assessment, Cardiac Computed Tomography Angiography-Guided Preprocedural Assessment - Nonvalvular Atrial Fibrillation | Not applicable | Recruiting | Shanghai Zhongshan Hospital | 590 | 2026-09-01 | 2026-09-11 |
| Apixaban Safety and Therapy Adherence in Patients With Atrial Fibrillation Apixaban - Nonvalvular Atrial Fibrillation | Recruiting | Bosnalijek D.D | 800 | 2025-10-09 | 2026-03-11 | |
| Non-antithrombotic Versus. Single Antiplatelet Therapy Following Left Atrial Appendage Closure Single Antiplatelet Therapy or No Therapy (Control), Non-Antithrombotic Therapy - Nonvalvular Atrial Fibrillation, Aspirin | Phase 4 | Recruiting | OCEAN-SHD Study Group | 500 | 2025-05-29 | 2025-08-15 |
| Pharmacokinetic Study to Evaluate Dabigatran Etexilate in Elderly Subjects Dabigatran etexilate capsule - Nonvalvular Atrial Fibrillation, Health, Subjective | Not applicable | Unknown | Dongyang Liu | 36 | 2022-08-15 | 2023-02-08 |
| First in Man Study of Left Atrial Appendage Pulsed Field Ablation Occluder E-SeaLA, CardioPulse PFA system - Nonvalvular Atrial Fibrillation | Not applicable | Unknown | Hangzhou Dinova EP Technology Co., Ltd | 10 | 2022-07-17 | 2024-01-17 |
| The Adherence to Oral Anticoagulant in Chinese Patients With NVAF adherence - Nonvalvular Atrial Fibrillation | Unknown | Second Affiliated Hospital, Zhejiang University, School of Medicine | 500 | 2021-07-20 | 2021-06-29 | |
| Watchman for Patients With Atrial Fibrillation Undergoing Transcatheter Mitral Valve Repair (WATCH-TMVR) MitraClip TMVR and Watchman LAAO - Nonvalvular Atrial Fibrillation, Severe Degenerative Mitral Regurgitation | Completed | Mayo Clinic | 25 | 2020-11-01 | 2026-05-01 | |
| Safety and Efficacy of Apixaban in Very Old Geriatric Subjects (> 80 Years) With Atrial FIbrillation in a Prospective reAl World Study; Nonvalvular Atrial Fibrillation | Completed | Gérond'if | 977 | 2020-09-23 | 2025-09-16 | |
| AntiCoagulants and COGnition Rivaroxaban 20 MG, Warfarin - Nonvalvular Atrial Fibrillation | Phase 4 | Unknown | University Hospital, Angers | 48 | 2020-02-13 | 2022-07-27 |
| Rivaroxaban vs Warfarin for SPAF in Multi-morbid Patients Rivaroxaban (Xarelto, BAY59-7939), Vitamin K antagonist (VKA) - Nonvalvular Atrial Fibrillation | Completed | Bayer | 78517 | 2017-12-01 | 2020-08-17 | |
| Benchmarking an Oral Anticoagulant Treatment Rate in Patients With Nonvalvular Atrial Fibrillation Nonvalvular Atrial Fibrillation | Completed | Baim Institute for Clinical Research | 817 | 2017-01-01 | 2022-07-27 | |
| Evaluation of Hospital Readmissions Among Hospitalized Non-valvular Atrial Fibrillation (NVAF) Patients in the US Nonvalvular Atrial Fibrillation | Completed | Bristol-Myers Squibb | 30000 | 2014-10-01 | 2016-04-07 | |
| Eliquis Safety Surveillance in Japanese Patients With NonValvular Atrial Fibrillation Eliquis - NonValvular Atrial Fibrillation | Completed | Bristol-Myers Squibb | 6372 | 2013-09-01 | 2022-06-07 | |
| Eliquis Regulatory Post Marketing Surveillance Apixaban - NonValvular Atrial Fibrillation | Completed | Bristol-Myers Squibb | 3335 | 2013-07-10 | 2017-10-31 | |
| Prevention of Stroke and Systemic Embolic Events in Patients With Atrial Fibrillation AZD0837, Vitamin-K antagonist at INR 2-3 - Nonvalvular Atrial Fibrillation | Phase 2 | Completed | AstraZeneca | 1084 | 2007-02-01 | 2012-03-23 |
Hemorrhage (1)
Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
apixaban (3) · Rivaroxaban (2) · Warfarin (2) · AZD 0837 (1) · Dabigatran (1) · acarboxyprothrombin (1)
Bristol-Myers Squibb (3) · AstraZeneca (1) · Baim Institute for Clinical Research (1) · Bayer (1) · Bosnalijek D.D (1) · Dongyang Liu (1) · Gérond'if (1) · Hangzhou Dinova EP Technology Co., Ltd (1) · Mayo Clinic (1) · OCEAN-SHD Study Group (1) · Second Affiliated Hospital, Zhejiang University, School of Medicine (1) · Shanghai Zhongshan Hospital (1) · University Hospital, Angers (1)
China (4) · United States (3) · France (2) · Japan (2) · Bosnia and Herzegovina (1) · Canada (1) · South Korea (1)
Christopher P Cannon, MD (1) · Dongyang Liu (1) · Gregory Y Lip, Prof (1) · Olivier Hanon, MD PhD (1) · Xiaochun Zhang (1)
PMID 19690349, PMID 22078863, PMID 30597611, PMID 31099460, PMID 31392894, PMID 31421933, PMID 31432074, PMID 32052379, PMID 35135065, PMID 42003301, PMID 4749689
2019 (1)